(Q40279586)

19 September 2017

title

Conjugated linoleic acid inhibits osteoclast differentiation of RAW264.7 cells by modulating RANKL signaling (English)

1 reference

19 September 2017

Md Mizanur Rahman

1

1 reference

19 September 2017

Arunabh Bhattacharya

series ordinal

2

1 reference

19 September 2017

Gabriel Fernandes

series ordinal

3

1 reference

19 September 2017

publication date

15 May 2006

1 reference

Journal of Lipid Research

19 September 2017

published in

1 reference

19 September 2017

volume

47

1 reference

19 September 2017

issue

8

1 reference

19 September 2017

page(s)

1739-1748

1 reference

Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis 1

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600151-JLR200

Therapeutic approaches to bone diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600151-JLR200

In vitro formation of osteoclasts from long-term cultures of bone marrow mononuclear phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600151-JLR200

Modulation of osteoclast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600151-JLR200

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600151-JLR200

TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600151-JLR200

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600151-JLR200

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600151-JLR200

Osteoclast differentiation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600151-JLR200

Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600151-JLR200

TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600151-JLR200

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600151-JLR200

Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600151-JLR200

Dietary conjugated linoleic acid in health: physiological effects and mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600151-JLR200

Conjugated linoleic acids: are they beneficial or detrimental to health?

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600151-JLR200

Mechanisms of action of conjugated linoleic acid: evidence and speculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600151-JLR200

Association between dietary conjugated linoleic acid and bone mineral density in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600151-JLR200

Effect of conjugated linoleic acid on body composition in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600151-JLR200

Bioactive fatty acids: role in bone biology and bone cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600151-JLR200

Inhibition of osteoporosis in autoimmune disease prone MRL/Mpj-Fas(lpr) mice by N-3 fatty acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600151-JLR200

Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600151-JLR200

Two histone deacetylase inhibitors, trichostatin A and sodium butyrate, suppress differentiation into osteoclasts but not into macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600151-JLR200

TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600151-JLR200

Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600151-JLR200

TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600151-JLR200

Conjugated linoleic acid and bone biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600151-JLR200

The effect of polyunsaturated fatty acids, including conjugated linoleic acid, on calcium absorption and bone metabolism and composition in young growing rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600151-JLR200

Effects of conjugated linoleic acid and exercise on bone mass in young male Balb/C mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600151-JLR200

Vav3 regulates osteoclast function and bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600151-JLR200

Bone resorption by osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600151-JLR200

Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600151-JLR200

Conjugated linoleic acid promotes human adipocyte insulin resistance through NFkappaB-dependent cytokine production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600151-JLR200

Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600151-JLR200

Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappa B ligand (RANKL)-induced JNK activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600151-JLR200

c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600151-JLR200

Bone and haematopoietic defects in mice lacking c-fos

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600151-JLR200

T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M600151-JLR200

10.1194/JLR.M600151-JLR200

21 January 2018

Identifiers

DOI

1 reference

19 September 2017

1 reference